Changmao Bio Schedules 18 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Dividend Proposal

Bulletin Express
Aug 03

Changmao Biochemical Engineering Company Limited (Changmao Bio) has announced that its board of directors will convene on 18 August 2026 at 3:00 p.m. in the People’s Republic of China.

The agenda includes: 1. Approval of the unaudited interim results for the six months ended 30 June 2026 and endorsement of the corresponding results announcement for publication on the Hong Kong Stock Exchange website. 2. Consideration of an interim dividend payout, if any. 3. Review of any necessary closure period for the Register of Members. 4. Discussion of other routine corporate matters.

The meeting notice was signed by Chairman Rui Xin Sheng on 3 August 2026. As of the announcement date, the board comprises three executive directors, three non-executive directors and three independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10